Invention Grant
- Patent Title: Stabilisation and isolation of extracellular nucleic acids
-
Application No.: US14347048Application Date: 2012-09-25
-
Publication No.: US10676780B2Publication Date: 2020-06-09
- Inventor: Martin Horlitz , Annabelle Schubert , Markus Sprenger-Haussels
- Applicant: QIAGEN GmbH
- Applicant Address: DE Hilden
- Assignee: QIAGEN GMbH
- Current Assignee: QIAGEN GMbH
- Current Assignee Address: DE Hilden
- Agency: Seed IP Law Group LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@59c2fdd2
- International Application: PCT/EP2012/068893 WO 20120925
- International Announcement: WO2013/045458 WO 20130404
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6806 ; C12N15/10 ; B01L3/00 ; B01L7/00
Abstract:
The present invention provides methods, compositions and devices for stabilizing the extracellular nucleic acid population in a cell-containing biological sample using an apoptosis inhibitor, preferably a caspase inhibitor, a hypertonic agent and/or a compound according to formula (1) as defined in the claims.
Public/Granted literature
- US20140227687A1 STABILISATION AND ISOLATION OF EXTRACELLULAR NUCLEIC ACIDS Public/Granted day:2014-08-14
Information query
